The Global Parkinson’s disease therapeutics market is accelerating into a new era of scientific possibility and patient-centered innovation, with total valuation projected to climb from USD 5.46 Billion in 2023 to USD 10.12 Billion by 2032-a compound annual growth rate (CAGR) of 7.1% over the forecast period. This sustained expansion is driven by...